Ottawa Heart Conference 2018: Precision Medicine in Cardiovascular Disease

6th annual International Ottawa Heart Conference banner

6th International Ottawa Heart Conference • Precision Medicine in Cardiovascular Disease

April 26-27, 2018 • National Arts Centre, Ottawa

Registration is now open

Register online

Conference brochure

Download the conference brochure.

2018 Conference brochure (pdf)

This two day event held April 26 and 27 at the National Arts Centre in downtown Ottawa will focus on Precision Medicine in Cardiovascular Disease and will highlight recent advancements and breakthroughs in preventing and treating cardiovascular disease in a precise targeted manner. The conference will feature some of the latest in systems biology, big data analytics, biomarkers, disease-in-a-dish modelling and personalized health innovations. The science will address impacts on cardiometabolic diseases, atherosclerosis, cardiac arrhythmias and heart failure.

This accredited event will bring together translational scientists, clinician scientists, cardiologists and trainees in cardiovascular science, and will facilitate scientific dialogue, exchange of information, and networking that will enable international collaborative opportunities. Additional sessions outside of plenary lectures will include a trainee career networking event and a public lecture.

Distinguished speakers include:

  • Victor Dzau, MD, President, National Academy of Medicine, Washington, DC and the James B Duke Professor of Medicine at Duke University. Giving the Wilbert J. Keon Endowed Lectureship.
  • Kiran Musunuru, MD, PhD, MPH, FAHA, Associate Professor of Cardiovascular Medicine and Genetics in the Perelman School of Medicine at the University of Pennsylvania.
  • Joseph C. Wu, MD, PhD, Director of the Stanford Cardiovascular Institute and Simon H. Stertzer Professor of Medicine (Cardiology) and Radiology at the Stanford School of Medicine.
  • Zachary Laksman, MD, Director of the SPH Atrial Fibrillation Clinic and the SPH Inherited Arrhythmia Clinic, University of British Columbia Division of Cardiology and Cardiovascular Surgery.
  • Marlene Rabinovitch, MD, Professor of Pediatric Cardiology at Stanford University School of Medicine.
  • Jeffrey S. Berger, MD, MS, Director of Cardiovascular Thrombosis and Associate Professor of Medicine and Surgery in the Divisions of Cardiology, Hematology, and Vascular Surgery at the New York University School of Medicine.
  • Vesana Garovic, MD, PhD, Chair for Research, Division of Nephrology and Hypertension, Clinical Research Office and Office of Clinical Trials, Department of Medicine, Mayo Clinic

See the list of speakers confirmed for 2018:

Confirmed speakers »

Public Lecture in partnership with the Gairdner Foundation

Medical Breakthroughs: What are the Possible Game-Changers in the Near Future? How will they impact health and society?

Speaker: Victor J Dzau, MD

The world is confronted with the rising epidemics of cardiovascular disease, cancer, and aging.  Cardiovascular Disease is the number 1 cause of death globally with an estimated 17.7 million people died from CVDs in 2015, representing 31% of all global deaths. 

Details and registration »


National Arts Centre artist renderingThe 2018 Conference will be held at the National Arts Centre

Visit the NAC’s website 


The University of Ottawa Heart Institute would like to thank our Corporate Sponsors.

Logos: Boehringer Ingelheim and Lilly

Share This